Glaukos Corp. (GKOS)
108.72
+1.85
(+1.73%)
USD |
NYSE |
Dec 10, 16:00
108.76
+0.04
(+0.04%)
After-Hours: 20:00
Glaukos Free Cash Flow: -27.61M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.824B |
| Perspective Therapeutics, Inc. | -106.85M |
| Xtant Medical Holdings, Inc. | 5.123M |
| VolitionRX Ltd. | -19.64M |
| Catheter Precision, Inc. | -9.721M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.09M |
| Cash from Investing (Quarterly) | -3.993M |
| Cash from Financing (Quarterly) | 5.264M |
| Free Cash Flow Per Share (Quarterly) | -0.2043 |
| Free Cash Flow to Equity (Quarterly) | -11.02M |
| Free Cash Flow to Firm (Quarterly) | -10.53M |
| Free Cash Flow Yield | -0.45% |